CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-14
DOI
10.1038/s41418-021-00828-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Colorectal cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SDCBP/MDA-9/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway
- (2020) Ruijuan Du et al. ONCOGENE
- Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma
- (2019) Jian-Fang Ning et al. Nature Communications
- PAK4, a target of miR-9-5p, promotes cell proliferation and inhibits apoptosis in colorectal cancer
- (2019) Meihua Wang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- PA28α/β Promote Breast Cancer Cell Invasion and Metastasis via Down-Regulation of CDK15
- (2019) Shengnan Li et al. Frontiers in Oncology
- CDK14 involvement in proliferation migration and invasion of esophageal cancer
- (2019) Lingling Chen et al. Annals of Translational Medicine
- P21 activated kinase signaling in cancer
- (2018) Chetan K. Rane et al. SEMINARS IN CANCER BIOLOGY
- CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer
- (2018) Jie Xie et al. Theranostics
- Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- miR-455 inhibits breast cancer cell proliferation through targeting CDK14
- (2017) Bing Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Structure, biochemistry, and biology of PAK kinases
- (2017) Rakesh Kumar et al. GENE
- Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression
- (2017) Yitao Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Generation of stable PDX derived cell lines using conditional reprogramming
- (2017) Alexandra Borodovsky et al. Molecular Cancer
- Inhibitors of cyclin-dependent kinases as cancer therapeutics
- (2017) Steven R. Whittaker et al. PHARMACOLOGY & THERAPEUTICS
- PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway
- (2016) Zlata Vershinin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Knockdown of PFTAIRE Protein Kinase 1 (PFTK1) Inhibits Proliferation, Invasion, and EMT in Colon Cancer Cells
- (2016) Jiankang Zhu et al. ONCOLOGY RESEARCH
- ALS2CR7 (CDK15) attenuates TRAIL induced apoptosis by inducing phosphorylation of survivin Thr34
- (2014) Mi Hee Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PCTAIRE1 Phosphorylates p27 and Regulates Mitosis in Cancer Cells
- (2014) T. Yanagi et al. CANCER RESEARCH
- Cyclin-dependent kinases
- (2014) Marcos Malumbres GENOME BIOLOGY
- Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
- (2013) D. Siolas et al. CANCER RESEARCH
- MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells
- (2012) Zhigang Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Group I and II mammalian PAKs have different modes of activation by Cdc42
- (2012) Yohendran Baskaran et al. EMBO REPORTS
- Knockdown of PAK4 or PAK1 Inhibits the Proliferation of Mutant KRAS Colon Cancer Cells Independently of RAF/MEK/ERK and PI3K/AKT Signaling
- (2012) H. Tabusa et al. MOLECULAR CANCER RESEARCH
- β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
- (2012) Stephan P Tenbaum et al. NATURE MEDICINE
- PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity
- (2012) A D Whale et al. ONCOGENE
- p21-Activated kinase 4 promotes prostate cancer progression through CREB
- (2012) M-H Park et al. ONCOGENE
- Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
- (2010) B. W. Murray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell Cycle Control of Wnt Receptor Activation
- (2009) Gary Davidson et al. DEVELOPMENTAL CELL
- Cyclin-dependent kinases: a family portrait
- (2009) Marcos Malumbres et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started